Trial Profile
A multicenter, double-blind, placebo-controlled, parallel group study to examine the longer-term efficacy and safety of Meridia (sibutramine hydrochloride) in obese subjects
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 Apr 2008
Price :
$35
*
At a glance
- Drugs Sibutramine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 14 Apr 2008 New trial record.